Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Medulloblastoma, the most common malignant paediatric brain tumour, is currently treated with nonspecific cytotoxic therapies including surgery, whole-brain radiation, and aggressive chemotherapy. As medulloblastoma exhibits marked intertumoural heterogeneity, with at least four distinct molecular variants, previous attempts to identify targets for therapy have been underpowered because of small samples sizes. Here we report somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastomas. SCNAs are common in medulloblastoma, and are predominantly subgroup-enriched. The most common region of focal copy number gain is a tandem duplication of SNCAIP, a gene associated with Parkinson’s disease, which is exquisitely restricted to Group 4α. Recurrent translocations of PVT1, including PVT1-MYC and PVT1-NDRG1, that arise through chromothripsis are restricted to Group 3. Numerous targetable SCNAs, including recurrent events targeting TGF-β signalling in Group 3, and NF-κB signalling in Group 4, suggest future avenues for rational, targeted therapy.

• Publication year

  2012

• Venue

  Nature

• Publication date

  2012-07-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature11327PMID 22832581PMCID PMC3683624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012cited by this paper
• The clinical implications of medulloblastoma subgroups

  2012cited by this paper
• Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration.

  2012cited by this paper
• FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

  2011influential reference
• The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors.

  2011cited by this paper
• Medulloblastoma comprises four distinct molecular variants.

  2011cited by this paper
• NFKBIA Deletion in Glioblastomas

  2011cited by this paper
• Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• Molecular subgroups of medulloblastoma: the current consensus

  2011cited by this paper
• Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples

  2011cited by this paper
• NFKBIA deletion in glioblastomas.

  2011cited by this paper
• Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct

  2011cited by this paper
• GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

  2011cited by this paper
• OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas.

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

  2010cited by this paper
• Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma

  2010influential reference
• Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.

  2010cited by this paper
• Synphilin-1 exhibits trophic and protective effects against Rotenone toxicity.

  2010cited by this paper
• Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma

  2009influential reference
• Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449.

  2009cited by this paper
• Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma

  2009cited by this paper
• Smad2/3 activities are required for induction and patterning of the neuroectoderm in zebrafish.

  2009cited by this paper
• A small cell lung cancer genome reports complex tobacco exposure signatures

  2009cited by this paper
• The PVT‐1 oncogene is a Myc protein target that is overexpressed in transformed cells

  2007cited by this paper
• Caspase-3-derived C-terminal Product of Synphilin-1 Displays Antiapoptotic Function via Modulation of the p53-dependent Cell Death Pathway*

  2006cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006cited by this paper
• Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood.

  2005influential reference
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.

  2003cited by this paper
• Sorting Nexin 6, a Novel SNX, Interacts with the Transforming Growth Factor-β Family of Receptor Serine-Threonine Kinases*

  2001cited by this paper
• Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease

  2001cited by this paper
• Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.

  1999cited by this paper
• Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions

  1999cited by this paper
• Occurrence of different cancers in patients with Parkinson's disease

  1995cited by this paper
• Specific interaction of type I receptors of the TGF-beta family with the immunophilin FKBP-12.

  1994cited by this paper
• Effects of translocations on transcription from PVT

  1990cited by this paper
• The PVT gene frequently amplifies with MYC in tumor cells

  1989cited by this paper
• A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.

  1988cited by this paper

• The Occurrence of Gene Fusions in Thyroid Lesions and the Relation With Chronic Lymphocytic Thyroiditis

  2026cites this paper
• Mitoxantrone alters CD24/Siglec-10 expression in malignant brain tumor models

  2026cites this paper
• EZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities

  2026cites this paper
• Robust immobilization of uranium using biogenic FeS with lignocellulose from green plant waste

  2026cites this paper
• Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastoma.

  2026cites this paper
• EcDNA-borne structural variants drive oncogenic fusion transcript amplification.

  2026cites this paper
• Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model.

  2026cites this paper
• Medulloblastoma-Associated KBTBD4 Mutations Disrupt PP2A-A Orphan Quality Control

  2026cites this paper
• A multi-omics atlas of human hindbrain development

  2026cites this paper
• Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographical organization.

  2025cites this paper
• Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma

  2025cites this paper
• ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip

  2025influential citation
• Accurate fusion transcript identification from long- and short-read isoform sequencing at bulk or single-cell resolution

  2025cites this paper
• Oncogenic gene fusions in cancer: from biology to therapy

  2025cites this paper
• Epigenetic modifications and their roles in pediatric brain tumor formation: emerging insights from chromatin dysregulation

  2025cites this paper
• Extracranial Metastatic Medulloblastoma: Two Case Reports and Systematic Literature Review

  2025cites this paper
• Evolving Biology and Therapy of WNT-Activated Medulloblastoma.

  2025cites this paper
• Large language models enable tumor-type classification and localization of cancers of unknown primary from genomic data

  2025cites this paper
• Challenges and opportunities for treatment of medulloblastoma.

  2025cites this paper
• Ras-Responsive Element Binding Protein 1 regulates survival of Group 3 medulloblastoma

  2025cites this paper
• Wip1 enhances genotoxic stress-induced autophagy via ULK1 dephosphorylation in Medulloblastoma cells

  2025cites this paper
• Masters of Gene Expression: Transcription Factors in Pediatric Cancers

  2025cites this paper
• Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models

  2025cites this paper
• Human stem cell models for group 3 medulloblastoma uncover JARID1B as a regulator of the chromatin landscape

  2025cites this paper
• Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer

  2025cites this paper
• Insights into Extrachromosomal DNA in Cancer: Biogenesis, Methodologies, Functions, and Therapeutic Potential

  2025cites this paper
• Nanopore Sequencing Reveals Novel Alternative Splice Variants of EZH2 in Pediatric Medulloblastoma

  2025cites this paper
• Alternative spliceosomal protein Eftud2 mediated Kif3a exon skipping promotes SHH-subgroup medulloblastoma progression

  2025cites this paper
• Consistently processed RNA sequencing data from 50 sources enriched for pediatric data

  2025cites this paper
• EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAs

  2025cites this paper
• Of travelling homeoproteins and medulloblastomas

  2025cites this paper
• Establishment of Two Novel Ovarian Tumor Cell Lines with Characteristics of Mucinous Borderline Tumors or Dedifferentiated Carcinoma—Implications for Tumor Heterogeneity and the Complex Carcinogenesis of Mucinous Tumors

  2025cites this paper
• Epigenomic landscape of the developing human rhombic lip reveals gene regulatory network and non-coding loci of developmental, evolutionary, and disease relevance

  2025cites this paper
• KMT2D temporally activates neuronal transcriptional factor genes to mediate cerebellar granule cell differentiation

  2025cites this paper
• How is rosette formation in brain tumours linked with cerebrospinal fluid spread?

  2025cites this paper
• Medulloblastoma: biology and immunotherapy

  2025cites this paper
• Unlocking the Radiosensitizing Potential of MYC inhibition in Neuroendocrine Malignancies.

  2025cites this paper
• Cancer cells’ chamber of secrets: the link between micronuclei, chromothripsis and malignancy

  2025cites this paper
• Genome imbalance modulates the expression of long non-coding RNAs in maize.

  2025cites this paper
• GABAergic Influences on Medulloblastoma

  2025cites this paper
• G-quadruplexes as a source of vulnerability in BRCA2-deficient granule cell progenitors and medulloblastoma

  2025cites this paper
• The role of DNA methylation in directing treatment in medulloblastoma.

  2025cites this paper
• Aberrant histone modifications in pediatric brain tumors

  2025cites this paper
• MYCN as an oncogene in pediatric brain tumors

  2025cites this paper
• Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma

  2025cites this paper
• A pathway-informed mutual exclusivity framework to detect genetic interactions in pediatric cancer

  2025cites this paper
• Preservation and Clonal Behavior of Extrachromosomal DNA in Patient-Derived Xenograft Models of Childhood Cancers

  2025cites this paper
• Chimerism: A whole new perspective in gene regulation.

  2025cites this paper
• Comparative analysis of pediatric SHH medulloblastoma DAOY spheres and adherent monolayers: implications for medulloblastoma research

  2025cites this paper
• Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer

  2025cites this paper
• Hidden-driver inference reveals synergistic brain-penetrant therapies for medulloblastoma

  2025cites this paper
• Characterization of immune microenvironment associated with medulloblastoma metastasis based on explainable machine learning

  2025cites this paper
• Developmental Origins and Oncogenesis in Medulloblastoma.

  2025cites this paper
• OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma

  2025cites this paper
• Small-Molecule Drugs in Pediatric Neuro-Oncology

  2025cites this paper
• Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy

  2025cites this paper
• Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma

  2025influential citation
• Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements

  2025cites this paper
• Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS.

  2025cites this paper
• Liquid Biopsies for Monitoring Medulloblastoma: Circulating Tumor DNA as a Biomarker for Disease Progression and Treatment Response

  2024influential citation
• PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme

  2024cites this paper
• Transcriptional Regulation of Protein Synthesis by Mediator Kinase Represents a Therapeutic Vulnerability in MYC-driven Medulloblastoma

  2024cites this paper
• Development and validation of a 23-gene expression signature for molecular subtyping of medulloblastoma in a long-term Chinese cohort

  2024cites this paper
• DHODH Inhibition Suppresses MYC and Inhibits the Growth of Medulloblastoma in a Novel In Vivo Zebrafish Model

  2024cites this paper
• Nanopore Sequencing as a Cutting-Edge Technology for Medulloblastoma Classification.

  2024cites this paper
• Classification and Treatment of Pediatric Medulloblastoma

  2024cites this paper
• Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitro.

  2024cites this paper
• Research progress on fusion genes in tumours

  2024cites this paper
• Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study

  2024cites this paper
• Application of radiomics for diagnosis, subtyping, and prognostication of medulloblastomas: a systematic review

  2024cites this paper
• 3D genome topology distinguishes molecular subgroups of medulloblastoma

  2024cites this paper
• G-quadruplexes are a source of vulnerability in BRCA2 deficient granule cell progenitors and medulloblastoma

  2024cites this paper
• Neurosurgical short-term outcomes for pediatric medulloblastoma patients and molecular correlations: a 10-year single-center observation cohort study

  2024cites this paper
• Cancer fusion transcripts with human non-coding RNAs

  2024cites this paper
• Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma

  2024cites this paper
• Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma.

  2024cites this paper
• MYCN in human development and diseases

  2024cites this paper
• Chromothripsis in myeloid malignancies

  2024cites this paper
• Exploring a distinct FGFR2::DLG5 rearrangement in a low-grade neuroepithelial tumor: A case report and mini-review of protein fusions in brain tumors.

  2024cites this paper
• Mechanistic insights into medulloblastoma relapse.

  2024cites this paper
• Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors

  2024cites this paper
• Lnc PVT1 facilitates TGF-β1-induced human cardiac fibroblast activation in vitro and ISO-induced myocardial fibrosis in vivo through regulating MYC

  2024cites this paper
• Research Progress on Autophagy Mechanisms in Different Molecular Subtypes of Medulloblastoma

  2024cites this paper
• Childhood cancer mutagenesis caused by transposase-derived PGBD5

  2024cites this paper
• The pivotal role of irradiation‐induced apoptosis in the pathogenesis and therapy of medulloblastoma

  2024influential citation
• The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma

  2024cites this paper
• Cerebellar phenotypes in germline PTEN mutation carriers

  2024cites this paper
• VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma

  2024cites this paper
• Chromothripsis-Mediated Small Cell Lung Carcinoma

  2024cites this paper
• Arrested development: the dysfunctional life history of medulloblastoma

  2024cites this paper
• The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas

  2024cites this paper
• CTAT-LR-fusion: accurate fusion transcript identification from long and short read isoform sequencing at bulk or single cell resolution

  2024cites this paper
• Heterogeneity and tumoral origin of medulloblastoma in the single-cell era

  2024cites this paper
• An Integrated Approach Including CRISPR/Cas9-Mediated Nanopore Sequencing, Mate Pair Sequencing, and Cytogenomic Methods to Characterize Complex Structural Rearrangements in Acute Myeloid Leukemia

  2024cites this paper
• Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition

  2024cites this paper
• A therapeutically targetable positive feedback loop between lnc-HLX-2-7, HLX, and MYC that promotes group 3 medulloblastoma

  2024cites this paper
• A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing

  2024cites this paper
• Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression

  2024cites this paper
• Targeting Long Non-Coding RNAs in Cancer Therapy using CRISPR-Cas9 Technology: A Novel Paradigm for Precision Oncology.

  2023cites this paper
• Chronic AMPK inactivation slows SHH medulloblastoma progression by inhibiting mTORC1 signaling and depleting tumor stem cells

  2023cites this paper